These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 11322738)

  • 1. Complications of SSRI treatment.
    Walkup J; Labellarte M
    J Child Adolesc Psychopharmacol; 2001; 11(1):1-4. PubMed ID: 11322738
    [No Abstract]   [Full Text] [Related]  

  • 2. [Selective serotonin reuptake inhibitors (SSRI) in childhood and adolescence].
    Stilke D
    Z Kinder Jugendpsychiatr Psychother; 1997 May; 25(2):106-16. PubMed ID: 9459700
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy with selective serotonin reuptake inhibitors (SSRI). Indications, uses and risks].
    Ebert D
    Fortschr Med; 1996 Jul; 114(18-19):243-7. PubMed ID: 8766793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective serotonin reuptake inhibitors (SSRIs) in children and adolescents.
    Vitiello B
    J Child Adolesc Psychopharmacol; 2006; 16(1-2):7-9. PubMed ID: 16553524
    [No Abstract]   [Full Text] [Related]  

  • 5. The Diagnostic clinical Interview for Drug Withdrawal 1 (DID-W1) – New Symptoms of Selective Serotonin Reuptake Inhibitors (SSRI) or Serotonin Norepinephrine Reuptake Inhibitors (SNRI): inter-rater reliability.
    Cosci F; Chouinard G; Chouinard VA; Fava GA
    Riv Psichiatr; 2018; 53(2):95-99. PubMed ID: 29674777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential indications for the selective serotonin reuptake inhibitors.
    Boyer WF
    Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 5():5-12. PubMed ID: 1431022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressant drugs and the cardiovascular system: a comparison of tricylics and selective serotonin reuptake inhibitors and their relevance for the treatment of psychiatric patients with cardiovascular problems.
    Coupland N; Wilson S; Nutt D
    J Psychopharmacol; 1997; 11(1):83-92. PubMed ID: 9097898
    [No Abstract]   [Full Text] [Related]  

  • 8. Neonatal outcomes after late-gestation exposure to selective serotonin reuptake inhibitors.
    Grzeskowiak LE; Gilbert AL; Morrison JL
    J Clin Psychopharmacol; 2012 Oct; 32(5):615-21. PubMed ID: 22926594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors.
    Skop BP; Brown TM
    Psychosomatics; 1996; 37(1):12-6. PubMed ID: 8600488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensory disturbances associated with serotonin reuptake inhibitors: brief review.
    Praharaj SK; Arora M; Sarkhel S
    Hum Psychopharmacol; 2010 Apr; 25(3):216-21. PubMed ID: 20373472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy Complications Following Prenatal Exposure to SSRIs or Maternal Psychiatric Disorders: Results From Population-Based National Register Data.
    Malm H; Sourander A; Gissler M; Gyllenberg D; Hinkka-Yli-Salomäki S; McKeague IW; Artama M; Brown AS
    Am J Psychiatry; 2015 Dec; 172(12):1224-32. PubMed ID: 26238606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extrapyramidal symptoms with selective serotonin reuptake inhibitors.
    Arya DK
    Br J Psychiatry; 1994 Dec; 165(6):728-33. PubMed ID: 7881774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective serotonin reuptake inhibitors for children and adolescents.
    Kastelic EA; Labellarte MJ; Riddle MA
    Curr Psychiatry Rep; 2000 Apr; 2(2):117-23. PubMed ID: 11122943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved outcome in fluvoxamine-treated patients with SSRI-induced sexual dysfunction.
    Banov MD
    J Clin Psychiatry; 1999 Dec; 60(12):866-8. PubMed ID: 10665636
    [No Abstract]   [Full Text] [Related]  

  • 15. SSRI-induced apathy syndrome: a clinical review.
    Barnhart WJ; Makela EH; Latocha MJ
    J Psychiatr Pract; 2004 May; 10(3):196-9. PubMed ID: 15330228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SSRI use during pregnancy and risk for postpartum haemorrhage: a national register-based cohort study in Sweden.
    Skalkidou A; Sundström-Poromaa I; Wikman A; Hesselman S; Wikström AK; Elenis E
    BJOG; 2020 Oct; 127(11):1366-1373. PubMed ID: 32162458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefits exceed risks of newer antidepressant medications in youth--maybe not.
    Potter WZ
    Clin Pharmacol Ther; 2009 Oct; 86(4):357-9. PubMed ID: 19763114
    [No Abstract]   [Full Text] [Related]  

  • 18. Bleeding and selective serotonin reuptake inhibitors in childhood and adolescence.
    Lake MB; Birmaher B; Wassick S; Mathos K; Yelovich AK
    J Child Adolesc Psychopharmacol; 2000; 10(1):35-8. PubMed ID: 10755580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SSRI antidepressants: Medsafe's response to Professor Werry's letter.
    Jessamine S
    N Z Med J; 2008 Mar; 121(1270):97-101. PubMed ID: 18364761
    [No Abstract]   [Full Text] [Related]  

  • 20. Serotonin-selective reuptake inhibitor-induced enuresis in three pediatric cases.
    Hergüner S; Kilinçaslan A; Görker I; Tüzün U
    J Child Adolesc Psychopharmacol; 2007 Jun; 17(3):367-9. PubMed ID: 17630870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.